Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H(HK:9989)
HK$4.02+0.00 (+0.12%)
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H financials statements
HK$4.02
At close:+0.00 (+0.12%)
Want to see HK:9989 full AI Analyst Report?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Income Statement
2 Followers
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Income Statement
Last quarter (Q3 2026), Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total revenue was ¥1.22B, a decrease of 11.60% from the same quarter last year. In Q3, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's net income was ¥118.61M. See Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| ¥ 5.48B | ¥ 5.28B | ¥ 5.45B | ¥ 7.16B | ¥ 6.37B | |
| ¥ 1.74B | ¥ 1.76B | ¥ 1.80B | ¥ 2.33B | ¥ 2.03B | |
| ¥ 1.11B | ¥ 1.01B | ¥ 2.66B | ¥ 1.21B | ¥ 1.07B | |
| Depreciation and Amortization | ¥ 372.91M | ¥ 331.05M | ¥ 373.60M | ¥ 307.66M | ¥ 302.74M |
| ¥ 846.59M | ¥ 1.20B | ― | ¥ 1.37B | ¥ 726.64M | |
| ¥ 635.97M | ¥ 741.31M | ¥ -238.11M | ¥ 1.14B | ¥ 773.20M | |
| ¥ -233.73M | ¥ -15.08M | ― | ¥ -168.70M | ¥ -611.27M | |
| ¥ 402.24M | ¥ 726.23M | ― | ¥ 829.85M | ¥ 222.26M | |
| ¥ 349.49M | ¥ 646.74M | ― | ¥ 727.43M | ¥ 240.79M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.24 | ¥ 0.44 | ¥ -0.53 | ¥ 0.50 | ¥ 0.16 |
| Diluted EPS | ¥ 0.24 | ¥ 0.44 | ¥ -0.53 | ¥ 0.50 | ¥ 0.16 |
| Weighted Average Shares Outstanding | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B |
| Weighted Average Shares Outstanding (Diluted) | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B |
Currency in CNY
